/term/bs-deferred-policy-acquisition-costs/STU:SP4P Achieve Life Sciences (STU:SP4P) Deferred Policy Acquisitio
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Deferred Policy Acquisition Costs

Achieve Life Sciences (STU:SP4P) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.

Achieve Life Sciences (STU:SP4P) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Deferred Policy Acquisition Costs
Comparable Companies
BLUE OTLK ATOS GALT OBIO CAPR VERU YS PBYI OMER OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
ACHV:USA SP4P:Germany
Address
22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021
Website
https://www.achievelifesciences.com
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for nicotine addiction.